XERS: Hecht Beth discloses a sale

By AlphaYouPublished Oct 2, 2026Form 4

Stocks in this disclosure

Reported activity

Hecht Beth

Reporting filer

Hecht Beth reported Sale in Xeris Biopharma Holdings, Inc.: 16666 units of Common Stock, dated 2026-10-01. The full Form 4 contains 1 transaction entry.

Disclosed: Oct 2, 2026

Reported details

1 entry

All validated entries in this disclosure
Security	Owner	Date	Code	Action	Quantity	Price	Following holdings	Reporting delay	Filed terms and references
Common Stock	Hecht Beth	2026-10-01	S	Sale	16666	9.4079	1,111,130	1 day	Filed terms security Title: Common Stock transaction Date: 2026-10-01 transaction Form Type: 4 transaction Code: S equity Swap Involved: 0 id: F1 transaction Shares: 16666 transaction Price Per Share: 9.4079 id: F2 transaction Acquired Disposed Code: D shares Owned Following Transaction: 1111130 direct Or Indirect Ownership: D

Common Stock

Owner: Hecht Beth
Date: 2026-10-01
Code: S
Action: Sale
Quantity: 16666
Price: 9.4079
Following holdings: 1,111,130
Reporting delay: 1 day
Filed terms and references: Filed terms
security Title: Common Stock
transaction Date: 2026-10-01
transaction Form Type: 4
transaction Code: S
equity Swap Involved: 0
id: F1
transaction Shares: 16666
transaction Price Per Share: 9.4079
id: F2
transaction Acquired Disposed Code: D
shares Owned Following Transaction: 1111130
direct Or Indirect Ownership: D

Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.

Filing context

Quantities and prices are shown in the units filed. No trade value is inferred from their product.
Hecht Beth: See Remarks.
The filing reports a Rule 10b5-1 trading plan.
F1: The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 8, 2025.
F2: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.180 to $9.680, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Original sources

SEC ownership filing

Prepared automatically from public filing data. Report a correction.

Security

Owner

Date

Code

Action

Quantity

Price

Following holdings

Reporting delay

Filed terms and references

Common Stock

Hecht Beth

2026-10-01

Sale

16666

9.4079

1,111,130

1 day

Filed terms

security Title: Common Stock
transaction Date: 2026-10-01
transaction Form Type: 4
transaction Code: S
equity Swap Involved: 0
id: F1
transaction Shares: 16666
transaction Price Per Share: 9.4079
id: F2
transaction Acquired Disposed Code: D
shares Owned Following Transaction: 1111130
direct Or Indirect Ownership: D

Filing context

Quantities and prices are shown in the units filed. No trade value is inferred from their product.

Hecht Beth: See Remarks.

The filing reports a Rule 10b5-1 trading plan.

F1: The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 8, 2025.

F2: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.180 to $9.680, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.